US Physical Therapy Inc（USPH）財務資料USPHUS Physical Therapy Inc

US Physical Therapy Inc (USPH) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Physical therapy operations, accounting for 84.6% of total sales, equivalent to $167.68M. Another important revenue stream is Industrial injury prevention services. Understanding this composition is critical for investors evaluating how USPH navigates market cycles within the Healthcare Facilities & Services industry.

Evaluating the bottom line, US Physical Therapy Inc maintains a gross margin of 20.59%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 11.15%, while the net margin is 6.96%. These profitability ratios, combined with a Return on Equity (ROE) of 0.56%, provide a clear picture of how effectively USPH converts its operational activities into shareholder value.

In the context of the broader market, USPH competes directly with industry leaders such as NUTX and GDRX. With a market capitalization of $1.25B, it holds a significant position in the sector. When comparing efficiency, USPH's gross margin of 20.59% stands against NUTX's 67.04% and GDRX's 78.41%. Such benchmarking helps identify whether US Physical Therapy Inc is trading at a premium or discount relative to its financial performance.

US Physical Therapy has demonstrated solid revenue growth, with Q2 2026 revenue at $214.06 million, an increase of 8.5% year-over-year. However, net income has been inconsistent, with a recent loss of $1.84 million in Q1 2026, followed by a profit of $3.81 million in Q2 2026.